Polypeptide growth factors and angiogenesis.
Angiogenesis is the term used to describe the formation and development of blood vessels. The renewed interest in regulation and mechanistic aspects of angiogenesis depends on advances in the comprehension of metastatic dissemination of cancers, ischaemic heart disease and blood-brain barrier formation. Recently, many poly-peptide growth factors have been discovered which regulate the angiogenic process, most of them are stimulators and few inhibitors have been described. There is some evidence that many polypeptide growth factors employ prostanoids as second messengers. If this evidence will be extended to angiogenic factors, it will be possible to use inhibitors of prostaglandin H synthase and/or prostanoid receptor blockers in the control of tumour induced angiogenesis.
Tomasi
V
V
Department of Experimental Biology, University of Bologna, Italy.
Manica
F
F
Spisni
E
E
D000818:Animals; D006133:Growth Substances / Q000235:genetics / Q000502:physiology*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D010455:Peptides / Q000235:genetics / Q000502:physiology*
D006133:Growth Substances; D010455:Peptides